Related references
Note: Only part of the references are listed.A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines
George W. Carnell et al.
VACCINES (2021)
Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways
Manon Laporte et al.
JOURNAL OF VIROLOGY (2020)
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
Joanne Marie M. Del Rosario et al.
FRONTIERS IN IMMUNOLOGY (2020)
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century
Saverio Caini et al.
PLOS ONE (2019)
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
Raffael Nachbagauer et al.
NPJ VACCINES (2019)
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
Walter Ramage et al.
ANTIBODIES (2019)
The evolution of seasonal influenza viruses
Velislava N. Petrova et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers
Dibyendu Kumar Das et al.
CELL (2018)
Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?
Jessica Tan et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses
Claudia Maria Trombetta et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
Francesca Ferrara et al.
METHODS AND PROTOCOLS (2018)
Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans
Lu Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
Swati Verma et al.
PLOS ONE (2017)
Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
Francesca Ferrara et al.
METHODSX (2017)
Domestic Pigs Are Susceptible to Infection with Influenza B Viruses
Zhiguang Ran et al.
JOURNAL OF VIROLOGY (2015)
Pseudotype-based neutralization on assays for influenza: a systematic analysis
George William Carnell et al.
FRONTIERS IN IMMUNOLOGY (2015)
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
Lidewij C. M. Wiersma et al.
VACCINES (2015)
4Flu-an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
Martin Eichner et al.
BMC INFECTIOUS DISEASES (2014)
Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
Juan Carlos Tinoco et al.
VACCINE (2014)
Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family
Ben M. Hause et al.
MBIO (2014)
Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals
Eleonora Molesti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Burden of Influenza B: A Structured Literature Review
W. Paul Glezen et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
Jiri Beran et al.
BMC INFECTIOUS DISEASES (2013)
The Quadrivalent Approach to Influenza Vaccination
Raphael Dolin
JOURNAL OF INFECTIOUS DISEASES (2013)
Heterogeneity of the MDCK Cell Line and Its Applicability for Influenza Virus Research
Vladimir Y. Lugovtsev et al.
PLOS ONE (2013)
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
Stephanie Pepin et al.
VACCINE (2013)
Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
Mayo Yasugi et al.
PLOS PATHOGENS (2013)
Pseudotype-Independent Nonspecific Uptake of Gammaretroviral and Lentiviral Particles in Human Cells
Christine Voelkel et al.
HUMAN GENE THERAPY (2012)
Characterization of glycan binding specificities of influenza B viruses with correlation with hemagglutinin genotypes and clinical features
Ya-Fang Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
Danuta M. Skowronski et al.
PLOS ONE (2012)
Influenza virus binds its host cell using multiple dynamic interactions
Christian Sieben et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application
Otto-Wilhelm Merten et al.
HUMAN GENE THERAPY (2011)
Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine
Juergen Stech et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
Multifaceted roles for lipids in viral infection
Nicholas S. Heaton et al.
TRENDS IN MICROBIOLOGY (2011)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
Davide Corti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2010)
Jalview Version 2-a multiple sequence alignment editor and analysis workbench
Andrew M. Waterhouse et al.
BIOINFORMATICS (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition
Eva Boettcher et al.
VACCINE (2009)
The evolutionary dynamics of human influenza B virus
Rubing Chen et al.
JOURNAL OF MOLECULAR EVOLUTION (2008)
Diversity in cell surface sialic acid presentations: implications for biology and disease
Nissi M. Varki et al.
LABORATORY INVESTIGATION (2007)
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies
Nigel J. Temperton et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium
Eva Böttcher et al.
JOURNAL OF VIROLOGY (2006)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol
XB Lu et al.
JOURNAL OF GENE MEDICINE (2004)
Antigenic characterisation of influenza B virus with a new microneutralisation assay: Comparison to haemagglutination and sequence analysis
F Ansaldi et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood
S Guindon et al.
SYSTEMATIC BIOLOGY (2003)
Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication
RJ Cox et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2002)
Share Paper
